Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

3 Meaningfully Undervalued Healthcare Stocks
Seeking Alpha
Tuesday, May 15, 2012 - 11:58am
tags:
JNJ, Emergent Health, Bristol-Myers Squibb
Amylin climbs after report says seven companies involved in sales process
Yahoo/Fly on the Wall
Tuesday, May 15, 2012 - 11:57am
tags:
Amylin, Pfizer, AstraZeneca, Sanofi, Merck, Takeda, Roche, Bristol-Myers Squibb, M&A
Roche Alzheimer's drug picked for major test
Reuters
Tuesday, May 15, 2012 - 11:55am
tags:
Roche, Alzheimer's disease, crenezumab
Furiex says J&J returns sexual dysfunction drug rights
Reuters
Tuesday, May 15, 2012 - 10:42am
tags:
JNJ, Furiex Pharmaceuticals, premature ejaculation, Priligy
GlaxoSmithKline's 4.8% Yield Makes It Attractive With Or Without Human Genome Takeover
Seeking Alpha
Tuesday, May 15, 2012 - 10:40am
tags:
GSK, Human Genome Sciences, Novartis, Pfizer, Roche
Zogenix takes smaller 1Q loss as sales pick up
Yahoo/AP
Tuesday, May 15, 2012 - 10:31am
tags:
earnings, Zogenix
New Caution Urged Over Sole Oral MS Drug On the Market
WSJ Online
Tuesday, May 15, 2012 - 10:30am
tags:
MS, multiple sclerosis, Novartis, Gilenya, FDA
Eli Lilly Is Ready To Soar On Strong Pipeline In 2013
Seeking Alpha
Tuesday, May 15, 2012 - 10:27am
tags:
Merck, Bristol-Myers Squibb, Eli Lilly, JNJ, Pfizer
Is This Biotech Upgrade Deserved?
Motley Fool
Tuesday, May 15, 2012 - 10:19am
tags:
Aeterna Zentaris, Keryx
Pozen Shares On The Rebound Since European Migraine Licensing Deal
Seeking Alpha
Monday, May 14, 2012 - 11:39am
tags:
Pozen, Europe, migraines, Desitin Arzneimittel GmbH, MT-400
Sales-needy Takeda springs for emerging markets growth
Fierce Pharma
Monday, May 14, 2012 - 11:37am
tags:
Takeda, emerging markets, M&A, Nycomed
Ventrus anal fissures cream meets goal; shares jump
Yahoo/AP
Monday, May 14, 2012 - 11:36am
tags:
Ventrus, anal fissure, VEN 307
Drug Approval! Oh, Wait, We Knew That Already.
Motley Fool
Monday, May 14, 2012 - 11:15am
tags:
drug approvals, Cell Therapeutics, Pixuvri, non-Hodgkin B-cell lymphoma, Europe
Mulling Arena Pharma's Future With Obesity Drug on Approval Path
TheStreet.com
Monday, May 14, 2012 - 11:14am
tags:
obesity, Arena Pharmaceuticals, FDA, lorcaserin
UK Pharma Trade Group May Restrict Samples
Pharmalot
Monday, May 14, 2012 - 11:12am
tags:
samples, UK, physicians
Prescribable Mobile Apps Huge Threat for Pharma
Forbes
Monday, May 14, 2012 - 10:38am
tags:
physicians, mobile apps
4 Big Pharma Stocks To Nab In A Pullback
Seeking Alpha
Monday, May 14, 2012 - 10:37am
tags:
Merck, Eli Lilly, Bristol-Myers Squibb, AstraZeneca
Teva Pharmaceuticals' Disappointing Results
Seeking Alpha
Monday, May 14, 2012 - 10:27am
tags:
Teva Pharmaceuticals, earnings
Loss Narrows at Auxilium
Yahoo/Zacks
Monday, May 14, 2012 - 10:22am
tags:
earnings, Auxilium
Myrexis Undervalued As BioPharma Transforms
Seeking Alpha
Monday, May 14, 2012 - 10:20am
tags:
Myrexis, JNJ, Abbott Laboratories, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.